The detailed information for PTAB case with proceeding number IPR2016-01095 filed by Luye Pharma Group Ltd. et al. against Alkermes Controlled Therapeutics, Inc. et al. on May 31, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2016-01095
Filing Date
May 31, 2016
Petitioner
Luye Pharma Group Ltd. et al.
Respondent
Alkermes Controlled Therapeutics, Inc. et al.
Status
Institution Denied
Respondent Application Number
10259949
Respondent Tech Center
1600
Respondent Patent Number
6667061
Institution Decision Date
Nov 30, 2016

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Jan 5, 2017PAPERBOARD

Request for Refund of Post-Institution Fees

Dec 21, 2016PAPERPETITIONER

Decision - Denying Institution of Inter Partes Review

Nov 30, 2016PAPERBOARD

Patent Owners' Preliminary Response (IPR1095)

Sep 1, 2016PAPERPATENT OWNER

Patent Owners' Exhibit List 1 (IPR1095)

Sep 1, 2016PAPERPATENT OWNER

DeLuca and Boylan - Ch 5 Pharm Dosage Form Parenteral Med.

Sep 1, 2016EXHIBITPATENT OWNER

European Pharmacopeia

Sep 1, 2016EXHIBITPATENT OWNER

USP 1995

Sep 1, 2016EXHIBITPATENT OWNER

Duma et al - Ch 2 Pharm Dosage Form Parenteral Med

Sep 1, 2016EXHIBITPATENT OWNER

Boylan and Fites - Ch 13 Modern Pharma

Sep 1, 2016EXHIBITPATENT OWNER

Remingtons 16th edition

Sep 1, 2016EXHIBITPATENT OWNER

Remingtons 17th edition

Sep 1, 2016EXHIBITPATENT OWNER

Patent Owners' Amended Mandatory Notices

Jun 30, 2016PAPERPATENT OWNER

Patent Owners' Mandatory Notices Uncer 37 C.F.R. 42.8(a)(2)

Jun 21, 2016PAPERPATENT OWNER

Power of Attorney

Jun 20, 2016PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Notice of Filing Date Accorded to Petition

Jun 3, 2016PAPERBOARD

Power of Attorney

May 31, 2016PAPERPETITIONER

Power of Attorney

May 31, 2016PAPERPETITIONER

Power of Attorney

May 31, 2016PAPERPETITIONER

Power of Attorney

May 31, 2016PAPERPETITIONER

Petition for IPR of Claims 1-13 and 17-23 of U.S. Patent No. 6,667,061

May 31, 2016PAPERPETITIONER

Transmittal Letter re Exhibits

May 31, 2016PAPERPETITIONER

U.S. Patent No. 6,667,061

May 31, 2016EXHIBITPETITIONER

Declaration of Dr. Patrick P. DeLuca

May 31, 2016EXHIBITPETITIONER

Curriculum Vitae of Dr. Patrick P. DeLuca

May 31, 2016EXHIBITPETITIONER

International Publication No.WO199901114

May 31, 2016EXHIBITPETITIONER

International Publication No.WO1995013799

May 31, 2016EXHIBITPETITIONER

US Pharmacopeia Entry re CMC

May 31, 2016EXHIBITPETITIONER

EP Pharmacopoeia Entry re CMC

May 31, 2016EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients

May 31, 2016EXHIBITPETITIONER

U.S. Patent No. 5,656,299

May 31, 2016EXHIBITPETITIONER

Lieberman et al., Pharmaceutical Dosage Forms Disperse System

May 31, 2016EXHIBITPETITIONER

U.S. Patent No. 6,495,164

May 31, 2016EXHIBITPETITIONER

Serial No. 10/259,949, Office Action, Apr. 9, 2003

May 31, 2016EXHIBITPETITIONER

Serial No. 10/259,949, Applicants Resp., May 14, 2003

May 31, 2016EXHIBITPETITIONER

Serial No. 10/259,949, Declaration of Mark A. Tracy, May 17, 2002

May 31, 2016EXHIBITPETITIONER

Serial No. 10/259,949, Notice of Allowance, July 24, 2003

May 31, 2016EXHIBITPETITIONER

Avis et al. (eds.), 1 (Chs.2,4, 5) Pharmaceutical Dosage Forms

May 31, 2016EXHIBITPETITIONER

L. Lachman et al., The Theory and Practice of Industrial Pharmacy

May 31, 2016EXHIBITPETITIONER

Lieberman et al., Pharmaceutical Dosage Forms Disperse Systems

May 31, 2016EXHIBITPETITIONER

Orange Book entries for RISPERDAL

May 31, 2016EXHIBITPETITIONER